Jeffrey Stewart, MD
Family Medicine · Carrollton, TXNPI 1538145198
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,502 of the $6,410 with a category attached, or 85.8%. It is spread thinly across 46 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 320 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$1K
- AbbVie$779
- Abbott$520
- Gilead$493
- AstraZeneca$450
- Novo Nordisk$283
- plus $3K from 40 others
Across 808 payments — averaging $7089.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$4.2M
- Incyte Corporation$370K
- Romark Laboratories, LC$344K
- Sanofi US Services Inc.$216K
- Alnylam Pharmaceuticals Inc.$156K
- AbbVie$115K
- plus $332K from 8 others
What the payments were for
- Travel & lodging$90814%
- Food & beverage$5,50286%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$6,410 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 34 | $32,573 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $5,912 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,906 |
| Levothyroxine Sodium | 170 | $1,622 |
| PaxlovidNirmatrelvir/Ritonavir | 14 | $1,429 |
| Potassium Chloride | 28 | $1,259 |
| Armour ThyroidThyroid,pork | 13 | $996 |
| Bupropion XlBupropion Hcl | 33 | $940 |
| Atorvastatin Calcium | 95 | $745 |
| Ezetimibe | 20 | $744 |
| Tamsulosin Hcl | 36 | $629 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $617 |
| Omeprazole | 49 | $553 |
| Metformin Hcl | 79 | $538 |
| Zolpidem Tartrate | 63 | $487 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $270 | $32,57334 claims |
| GSKAnoro Ellipta, Breo Ellipta | $274 | $10,81825 claims |
| PfizerPaxlovid | $148 | $1,42914 claims |
| AbbVieArmour Thyroid | $779 | $99613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Carrollton
- Rodney LindsayCarrollton$225K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.